March 29, 2020

Pancreatic Fistula Treatment Market Expected To Exhibit Steady Growth Rate During The Forecast Period

The latest market report published by Credence Research, Inc. “Pancreatic Fistula Treatment Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global pancreatic fistula treatment market was valued at US$ 1,708.6 Mn in 2017 expanding at a CAGR of 5.7% from 2018 to 2026.

Access Free Sample Copy of Research Report

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Market Insights:

Pancreatic Fistula Treatment Market

Postoperative pancreatic fistula (POPF) is known as one of the major medical complications and is a potentially chronic, life-threatening occurrence that prolongs hospital stays and raises healthcare costs. A research study published by Mosby suggested that, after pancreatic duodenectomy, the reported POPF rate is highly variable, ranging from 2% to more than 20%, based on the prevalence of pancreatic cancer and population density of each country or region. There are three types of pancreatic fistulas, such as high output fistula, mixed fistula and final fistula. In the case of high fistula, the fluid production is greater than 200 mL in 24 hours; mixed fistulas drain pancreatic fluid along with enteric content; and in the case of final fistula, the pancreatic duct splits in form. As a consequence, POPF is usually managed through procedures such as pancreatic duct ligation, pancreatic duct obliteration, pancreatic jejunostomy, and pancreatic gastrostomy. Different treatment regimens include sepsis management, fluid and electrolyte balance maintenance somatostatin analog, percutaneous therapy, and surgery.

In terms of treatment, pancreatic fistula therapy is divided into medications and surgical instruments. The drug segment is further classified as octreotide and total parenteral nutrition (TPN). The category of surgical devices is expected to dominate the market during the forecast period due to the relatively higher penetration of medical devices to diagnose and treat pancreatic fistula. Improved releases of generic drugs and octreotide pipelines in clinical trials are expected to support market growth in the near future. The total parenteral nutrition segment dominated the drug market in 2017 due to increased demand for parenteral nutritional products, including a single-dose amino acid solution, carbohydrates, parenteral lipid emulsion, trace elements, vitamins and minerals, as it suppresses the production of pancreatic enzymes by reducing the oral intake of food and preserving the patient’s diet. In addition, the extensive use of sphincterotomes, biliary and pancreatic stents, guide wires, balloons and cannulae while performing ERCP for pancreatic fistula management promotes the dominance of the segment of surgical devices.

For Any Query, Ask Our Expert

North America accounted for the largest share of the global market for pancreatic fistula therapy due to key drivers such as increased prevalence of pancreatic cancer and pancreatic neuroendocrine tumors. In addition, increased awareness of post-operative complications of pancreatic duodectomy, pancreatic jejunostomy, and pancreatectomy among physicians is expected to fuel market growth. Asia Pacific is projected to experience rapid growth due to a growing geriatric population susceptible to pancreatic cancer, adenocarcinoma, pancreatic neuroendocrine tumors, and other gastrointestinal and lifestyle diseases. Growing healthcare infrastructure for effective and preventive pancreatic surgery will increase the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices for the management of pre-and post-operative complications related to pancreatic surgery.

The prominent players actively engaged in the pancreatic fistula treatment market are Cook Medical, Inc., CONMED Corporation, Fresenius Kabi AG, B. Braun Melsungen Ag, Becton Dickinson & Company, Medtronic plc, Novartis AG and Others.

Browse Full Report Originally Published by Credence Research

Key Market Movements:

Rising prevalence of pancreatic cancer and neuroendocrine tumors worldwide
Growing cases of post-operative pancreatic fistula to drive the growth of pancreatic fistula treatment market
Organized guidelines for the treatment of pancreatic fistula

Leave a Reply

Your email address will not be published. Required fields are marked *